NSE - Delayed Quote INR
GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)
2,802.70
-113.30
(-3.89%)
At close: 3:30:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
5,820,155
4,842,254
8,107,478
5,779,109
Investing Cash Flow
--
87,117
8,078,514
-4,055,076
4,180,263
Financing Cash Flow
--
-5,614,969
-15,433,230
-5,242,423
-6,955,595
End Cash Position
--
641,712
349,409
2,861,871
4,051,892
Capital Expenditure
--
-312,215
-440,391
-346,410
-442,266
Repayment of Debt
--
--
--
-240
-1,530
Free Cash Flow
--
5,507,940
4,401,863
7,761,068
5,336,843
3/31/2021 - 7/1/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SANOFI.NS Sanofi India Limited
6,273.00
-4.51%
PFIZER.NS Pfizer Limited
4,248.90
-0.63%
GS70.SG GSK PLC
32.80
+3.80%
TTKHLTCARE.BO TTK HEALTHCARE LTD.
1,233.80
+0.44%
GS70.HM GSK PLC
32.80
0.00%
IDP.DE Biogen Inc.
103.85
-1.56%
ROGz.XC
GS71.DE GSK plc
16.37
-0.33%
SANOFICONR.NS SANOFI CONS HEALTHC IND L
4,939.00
+0.03%
KOPRAN.NS Kopran Limited
190.58
-4.16%